News

  • 9 April 2015

    Mobidiag launches Amplidiag qPCR-based test

    Finnish molecular diagnostics company Mobidiag has launched Amplidiag C difficile+027, a qualitative qPCR-based test carried out using DNA extracted from stool in suspected cases of clostridium difficile infection (CDI).